Trade Name: IRISpec CA / CB / CC; registration number 10033120952; risk class II; lot / series: 004-16 (distributed as follows: 1 in Ceará, 5 in Rio de Janeiro, 3 in Espírito Santo, 2 in Paraná, 1 in Santa Catarina, 1 in Minas Gerais, 34 in São Paulo, 1 Pará, 6 in Maranhão and 2 in Bahia). 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Beckman Coulter do Brasil Comercio e Importação de Produtos para Laboratório Ltda; IRIS Diagnostics a Division of Iris Internacional Inc. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1872
  • 날짜
    2016-05-02
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    Recommendations to Users and Patients: If the laboratory is using any of the listed batches: • Follow the instructions for handling and storing the quality control material in accordance with the product's current package insert (IFU) to avoid premature degradation due to the technique inadequate. Bulletin Number (IFU) 300-1223. • If the IRISpec CA control for the bilirubin parameter fails, discard the vial and use another vial of the same control that accompanies the kit. Each kit consists of 3 vials of the AC control. • If the problem persists, request product replacement by contacting the customer service area at 11 4154-8818 or lmanzan@beckman.com
  • 원인
    On 12.04.2016 beckman coulter of brazil received beckman coulter inc. from its parent company, an email with an important product notice, reporting a problem regarding the premature degradation of bilirubin for some specific batches may lead to failures in the bilirubin control material in the irispec ca product. - irispec ca control may fail for specific bilirubin analyte. -the laboratory will be unable to process the patient samples until the approvals of the quality control (qc). -not all bottles within a specific lot may be affected.
  • 조치
    Action code IPN-25316. Letter with instructions for customers /// If problem persists with lot 004-16, registration holder will start collecting the product.